Bluejay Diagnostics (BJDX) Research & Development (2020 - 2026)
Bluejay Diagnostics recorded quarterly Research & Development of $811837.0 in Q1 2026, up 38.5% quarter-over-quarter from $586144.0 in Q4 2025, and up 3.45% year-over-year from $784800.0 in Q1 2025.
Bluejay Diagnostics' Research & Development history runs 7 years deep, the most recent figure standing at $811837.0 for Q1 2026.
- In Q1 2026, Research & Development rose 3.45% year-over-year to $811837.0; the TTM figure through Mar 2026 stood at $3.1 million (up 5.15% YoY), while the FY2025 annual figure was $3.0 million, down 12.25% from the prior year.
- Research & Development came in at $811837.0 for Q1 2026 at Bluejay Diagnostics, up from $586144.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.7 million in Q2 2023 to a low of $551655.0 in Q3 2024.
- A 5-year average of $1.0 million and a median of $889896.0 in 2025 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 2772.91% in 2022 and slumped 60.52% in 2024, its largest moves.
- Bluejay Diagnostics' Research & Development stood at $1.3 million in 2022, then retreated by 2.65% to $1.3 million in 2023, then plunged by 56.94% to $553997.0 in 2024, then grew by 5.8% to $586144.0 in 2025, then soared by 38.5% to $811837.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $811837.0, $586144.0, and $785608.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 811,837.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 811,837.00 |
| Dec 31, 2025 | 586,144.00 |
| Sep 30, 2025 | 785,608.00 |
| Jun 30, 2025 | 889,896.00 |
| Mar 31, 2025 | 784,800.00 |
| Dec 31, 2024 | 553,997.00 |
| Sep 30, 2024 | 551,655.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 756,283.00 |
| Mar 31, 2022 | 694,757.00 |
| Dec 31, 2021 | 455,253.00 |
| Sep 30, 2021 | 442,527.00 |
| Jun 30, 2021 | 225,992.00 |
| Mar 31, 2021 | 24,183.00 |
| Dec 31, 2020 | 419,061.00 |
| Sep 30, 2020 | 2,723.00 |